BOPA 2023 | The importance of product approvals for cancer medications

Phil Jones, Pharmacy Workforce Development South, Bristol, UK, discusses the intricacies of approving medications in the oncology space. Beyond an accuracy check, the final product must undergo stringent monitoring as if were a food product in terms of expiration and ingredients. Furthermore, the manufacturing, provenance of the components and staff competency are additionally scrutinized. This interview took place at the 26th Annual British Oncology Pharmacy Association (BOPA) Symposium in Newport, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.